Philippe Camus, M.D.

Dijon, France

Back

The Drug-Induced Respiratory Disease Website

Lidocaine (lignocaine, xylocaine)

I - Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)

I.a

Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
I.l

Cardiac- cardiorespiratory/pulmonary arrest

X - Pulmonary edema

X.b

Pulmonary edema, noncardiogenic (NCPE)
X.g

Flash (fulminate) pulmonary edema
X.h

Negative pressure pulmonary edema (NPPE)

XXII - Acute respiratory/cardiorespiratory failure

XXII.b

Acute lung injury - ARDS

XXIII - Hemoglobinopathies (acquired, reversible)

XXIII.a

Methemoglobinemia

XXVIII - Large airway involvement

XXVIII.a

Angioedema (may cause UAO, asphyxia and death)
XXVIII.q

Central airway instability - Tracheomalacia

XXIX - Small airway involvement

XXIX.a

Bronchospasm - Wheezing - Asthma
XXIX.c

Severe or catastrophic bronchospasm or asthma attack (can be fatal)

XXXVI - Autoimmune syndromes - Systemic reactions or conditions

XXXVI.f

Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)

XXXVIII - Miscellaneous - Varia

XXXVIII.d

Death following exposure or poisoning
XXXVIII.f

Cyanosis, a low SpO2 and normal measured PaO2